Analysis of stool samples is a frequent task in clinical diagnostics. Heike Calado Duarte and Carlo Farah from our R&D team talk to us about the challenges involved and what you should pay [...]
During the COVID-19 pandemic, there were significantly fewer infections with diarrhea-causing pathogens such as norovirus. However, with the relaxation of countermeasures against COVID-19, the [...]
The Omicron variant does not show any mutations in the areas detected by our assays and is therefore positively detected by RIDA®GENE SARS-CoV-2 (Art. No. PG6815/ PG6820) and RIDA®GENE Flu & [...]
The bacteria Clostridium difficile colonizes every human intestine, although it may be harmful for those with compromised immune systems. It is becoming increasingly prevalent in hospitals. What [...]
For World IBD Day we would like to draw your attention to the Inflammatory Bowel Disease (IBD). About ten million people worldwide (around three million in Europe) suffer from this chronic [...]
The COVID-19 infection figures continue to rise and with them the fear: How long can regular school operations be maintained? Experts warn of renewed school closings and recommend specific measures.
Helicobacter pylori can cause serious diseases. The symptoms of a Helicobacter infection vary widely in their form and expression. Detection is therefore critical for diagnosis and treatment. [...]
In February 2020, R-Biopharm was one of the first diagnostics companies worldwide to launch a test kit for the novel coronavirus SARS-CoV-2. Now, the test has received the CE label and is thus [...]
Infection with the stomach bacteria Helicobacter pylori is the most common cause of stomach inflammation (gastritis). Yet, these widespread bacteria can also cause many other diseases—possibly [...]
